Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ULTRAGENYX-PHARMACEUTICAL-15672076/news/Ultragenyx-Announces-Positive-Longer-term-Durability-Data-from-Two-Phase-1-2-Gene-Therapy-Studies-at-40477663/?utm_source=whatsapp&utm_medium=social&utm_campaign=share